What is Vir Biotechnology, Inc.'s revenue?

Vir Biotechnology, Inc. (VIR) generated $65.5M in revenue over the trailing twelve months, up 214.0% year over year.

Is Vir Biotechnology, Inc. profitable?

Vir Biotechnology, Inc. is not currently profitable: it reported a net loss of $442.7M over the trailing twelve months, a -676.0% net margin.

What are Vir Biotechnology, Inc.'s profit margins?

Gross margin is 96.1% and operating margin is -720.8%, with a -676.0% net margin.

What is Vir Biotechnology, Inc.'s earnings per share?

Vir Biotechnology, Inc.'s diluted EPS over the trailing twelve months is $-3.12.

Where does Vir Biotechnology, Inc.'s income statement data come from?

Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Vir Biotechnology, Inc. VIR Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$65.5M-4.5%	$68.56M+307%	$16.86M-11.3%	$19M-8.9%	$20.86M-71.9%
Gross profit	——	——	——	$18.26M-9.1%	$20.08M-72.6%
Research and development	$446.24M-2.1%	$455.97M-3.7%	$473.7M-8.4%	$517.42M-1.4%	$525.02M+3.7%
Selling, general and administrative	$91.47M-0.7%	$92.07M-3.2%	$95.16M-3.6%	$98.67M-7.5%	$106.65M-10.4%
Total costs & expenses	$537.57M-1.9%	$547.88M-3.1%	$565.42M-9.6%	$625.42M-6.3%	$667.49M+0.9%
Operating income	-$472.07M+1.5%	-$479.33M+12.6%	-$548.56M+9.5%	-$606.42M+6.2%	-$646.63M-10.1%
Operating margin	-720.8%-21.6pp	-699.2%+2,554pp	-3,253.6%-61.9pp	-3,191.7%-92.0pp	-3,099.7%-2,308pp
Interest income	$35.14M-12.7%	$40.24M-13.6%	$46.59M-14.9%	$54.75M-12.8%	$62.81M-12.5%
Other income (expense), net	$29.73M-28.5%	$41.56M-15.5%	$49.17M-12.9%	$56.47M-16.4%	$67.58M+5.5%
Income before income taxes	-$442.35M-1.0%	-$437.77M+12.3%	-$499.39M+9.2%	-$549.95M+5.0%	-$579.05M-10.7%
Income tax expense	——	——	$268K-3.2%	$277K+120%	-$1.41M-22.7%
Net income	-$442.72M-1.1%	-$437.99M+12.3%	-$499.65M+9.2%	-$550.23M+4.7%	-$577.65M-10.7%
Net margin	-676%-37.1pp	-638.9%+2,325pp	-2,963.5%-67.6pp	-2,895.9%-127pp	-2,769%-2,066pp
Diluted earnings per share	-$3.12+1.0%	-$3.15+12.7%	-$3.61+9.7%	-$4.00+5.2%	-$4.22-10.5%
Basic earnings per share	-$3.12+1.0%	-$3.15+12.7%	-$3.61+9.7%	-$4.00+5.2%	-$4.22-10.5%
Weighted-average shares, diluted	563.3M+1.8%	553.4M+0.4%	551.1M+0.4%	548.8M+0.4%	546.6M+0.4%
Weighted-average shares, basic	563.3M+1.8%	553.4M+0.4%	551.1M+0.4%	548.8M+0.4%	546.6M+0.4%
Gain on retained interest in Sandisk	——	——	$3.16M+6.9%	$2.96M-56.3%	$6.77M+222%
Other income, net (Note 6)	-$591K-44.5%	-$409K+29.5%	-$580K+53.4%	-$1.25M+37.9%	-$2.01M+9.7%
Restructuring Costs And Asset Impairment Charges	-$172K+5.5%	-$182K—	——	——	——
EBIT	-$472.07M+1.5%	-$479.33M+12.6%	-$548.56M+9.5%	-$606.42M+6.2%	-$646.63M-10.1%
EBITDA	-$460.45M+1.5%	-$467.65M+12.9%	-$536.89M+9.7%	-$594.85M+6.1%	-$633.72M-10.7%
EBITDA	-$460.45M+1.5%	-$467.65M+12.9%	-$536.89M+9.7%	-$594.85M+6.1%	-$633.72M-10.7%
EBITDA margin	-703%-20.9pp	-682.1%+2,502pp	-3,184.4%-53.6pp	-3,130.8%-93.0pp	-3,037.8%-2,266pp
EBIT	-$472.07M+1.5%	-$479.33M+12.6%	-$548.56M+9.5%	-$606.42M+6.2%	-$646.63M-10.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Vir Biotechnology, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s revenue?: Vir Biotechnology, Inc. (VIR) generated $65.5M in revenue over the trailing twelve months, up 214.0% year over year.
Is Vir Biotechnology, Inc. profitable?: Vir Biotechnology, Inc. is not currently profitable: it reported a net loss of $442.7M over the trailing twelve months, a -676.0% net margin.
What are Vir Biotechnology, Inc.'s profit margins?: Gross margin is 96.1% and operating margin is -720.8%, with a -676.0% net margin.
What is Vir Biotechnology, Inc.'s earnings per share?: Vir Biotechnology, Inc.'s diluted EPS over the trailing twelve months is $-3.12.
Where does Vir Biotechnology, Inc.'s income statement data come from?: Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.